Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case-control study within a screening setting
- PMID: 39548535
- PMCID: PMC11567874
- DOI: 10.1002/ctm2.70068
Confirmation of previously identified plasma microRNA ratios for breast cancer detection in a nested case-control study within a screening setting
Figures


References
-
- Giordano L, Gallo F, Petracci E, Chiorino G, Segnan N, the Andromeda working group . The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol. BMC Cancer. 2017;17:785. - PMC - PubMed
-
- Aggarwal V, Priyanka K, Tuli HS. Emergence of circulating MicroRNAs in breast cancer as diagnostic and therapeutic efficacy biomarkers. Mol Diagn Ther. 2020;24:153‐173. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources